【MGRC 0155 交流专区】基因组学资源

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Jun 2024

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Jun 2024	30 Jun 2023	30 Jun 2024	30 Jun 2023
		$$'000	$$'000	$$'000	$$'000

1	Revenue	1,303	2,229	3,077	0
2	Profit/(loss) before tax	-1,411	-9,984	-2,907	0
3	Profit/(loss) for the period	-1,411	-11,078	-2,907	0
4	Profit/(loss) attributable to ordinary equity holders of the parent	-1,333	-11,031	-2,741	0
5	Basic earnings/(loss) per share (Subunit)	-0.97	-8.47	-2.00	0.00
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.1400		0.1600

icy97

Type	Announcement
Subject	OTHERS
Description	MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD (MGRC OR COMPANY)- DISTRIBUTORSHIP AGREEMENT BETWEEN MGRC BIOPHARMA SDN BHD AND BIOMAB, INC.
For details of this announcement kindly refer to the attachment. This announcement is dated 9 September 2024.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3482129

Attachments MGRC_ Distribution Agreement _MGRCBiopharma with BioMab_final.pdf